FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

Contineum Therapeutics, Inc.: operating_income

One fact, its scope and the complete path back to the official record.

Period: 2023-01-01 – 2023-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/80827097-a5b2-49fd-a95e-cf12e54c9cfa

Reported value

$16.077M{"amount": 16077000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"}
Entity
Contineum Therapeutics, Inc.
Metric
operating_income
Period
2023-01-01 – 2023-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001437749-25-006458 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T18:40:47.493819+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001855175/operating-income/2023-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.